Man Group’s ClearPoint Neuro CLPT Stock Holding History

Man Group’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,520	Closed	-$144K	–	2419
2025 Q4	$144K	Sell	10,520 -17,950	-63%	-$333K	﹤0.01%	2163
2025 Q3	$620K	Sell	28,470 -43,414	-60%	-$511K	﹤0.01%	1803
2025 Q2	$858K	Buy	71,884 +10,674	+17%	+$134K	﹤0.01%	1667
2025 Q1	$728K	Sell	61,210 -10,777	-15%	-$168K	﹤0.01%	1670
2024 Q4	$1.11M	Buy	+71,987	New	+$932K	﹤0.01%	1461
2023 Q1	–	Sell	-15,124	Closed	-$132K	–	1924
2022 Q4	$128K	Buy	+15,124	New	+$143K	﹤0.01%	1867
2022 Q2	–	Sell	-24,007	Closed	-$250K	–	2099
2022 Q1	$250K	Buy	+24,007	New	+$219K	﹤0.01%	1840

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Man Group's CLPT Position: Q1 2026 in Review

Man Group sold out of ClearPoint Neuro (CLPT) in Q1 2026, closing a stake of 10,520 shares — an estimated $144K sold.

Man Group first reported a position in CLPT in Q1 2022 and held it in 7 quarters. The position peaked at $1.11M in Q4 2024. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

Man Group reported no remaining ClearPoint Neuro position as of Q1 2026 after selling out during the quarter.
Man Group sold 10,520 ClearPoint Neuro shares in Q1 2026, an estimated $144K.
Man Group first reported a position in ClearPoint Neuro in Q1 2022 and held it in 7 quarters.
Man Group's ClearPoint Neuro position peaked at $1.11M in Q4 2024.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.